Bispecific Antibody Real-World Experience Study (Full Question Set)
About
This observational study aims to explore the real-world experiences of patients receiving bispecific antibodies as a treatment for multiple myeloma.
51 minutes
Rahul Banerjee, MD FACP, Fred Hutch Cancer Center; Caitlin Costello, MD, UC San Diego Health; Gurbakhas Kaur, MD, UT Southwestern Medical Center; Meera Mohan, MD, MS, FACP, Froedtert Medical College of Wisconsin; Francesca Cottini, MD, The Ohio State University, Comprehensive Cancer Center; Douglas Sborov, MD, MS, University of Utah, Huntsman Cancer Institute; Noopur Raje, MD, Massachusetts General Hospital; Shaji Kumar, MD, Mayo Clinic; Philippe Moreau, MD, University of Nantes, France
Contact Information
For any questions or concerns regarding the study, participants can contact HealthTree Patient Navigators at support@healthtree.org.